Bose S, Barroso M, Chheda MG, Clevers H, Elez E, Kaochar S, Kopetz SE, Li XN, Meric-Bernstam F, Meyer CA, Mou H, Naegle KM, Pera MF, Perova Z, Politi KA, Raphael BJ, Robson P, Sears RC, Tabernero J, Tuveson DA, Welm AL, Welm BE, Willey CD, Salnikow K, Chuang JH, Shen X
There is a lack of clear recommendations and evidence concerning the optimal timing for initiation of antihyperglycaemic therapy
The trials findings also suggest that bofanglutide could help manage diabetes and obesity
Kuldeep Singh, director of the Maryland Bariatric Center at Mercy Medical Center in Baltimore, MD who was not involved in this study told Medical News Today
This is one of the most common questions people ask, and the research is reassuring
In clinical trials, patients taking Tirzepatide have seen significant weight loss within the first 12 weeks of treatment